Summary
Altacor Ltd (Altacor) is an ophthalmology company that develops and markets products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products portfolio includes liquid gel, eye drop, eye mask, eyelid cleaner, nutritional supplement, and others. Altacor’s products are used for diseases such as dry eye syndrome, blepharitis and age-related macular degeneration. The company also provides laser surgery and filtering microsurgery to overcome glaucoma; ophthalmic surgery and cataract surgery. It markets its products throughout Europe. Altacor is headquartered in Cambridge, the UK.
Altacor Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Altacor Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Altacor Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Altacor Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Altacor Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Altacor Secures US$3 Million In Second Tranche Of Venture Financing 11
Private Equity 12
Esperante Acquires Altacor from Beringea 12
Partnerships 13
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product 13
Proximagen And Altacor Enter Into R&D Agreement For Treatment Of Glaucoma 14
Licensing Agreements 15
Altacor Enters Into Licensing Agreement With OphthalmoPharma For Latanoprost CD And Cyclosporin A Prodrug 15
Acquisition 16
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 16
Altacor Ltd - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
Altacor Ltd, Pharmaceuticals & Healthcare, Key Facts 1
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Altacor Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Altacor Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Altacor Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Altacor Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Altacor Secures US$3 Million In Second Tranche Of Venture Financing 11
Esperante Acquires Altacor from Beringea 12
Altacor Enters Into Co-Promotion Agreement With Norgine For Clinitas Dry Eye Product 13
Proximagen And Altacor Enter Into R&D Agreement For Treatment Of Glaucoma 14
Altacor Enters Into Licensing Agreement With OphthalmoPharma For Latanoprost CD And Cyclosporin A Prodrug 15
NicOx Completes Acquisition Of 11.8% Stake In Altacor For US$3 Million 16
Altacor Ltd, Key Competitors 18
Altacor Ltd, Key Employees 19
List of Figures
Altacor Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Altacor Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Altacor Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Altacor Ltd, Medical Devices Deals, 2011 to YTD 2017 9